Conferences and Meetings on Pharmacology and Drug Development

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.
 
World ADC Berlin — The 7th Annual World ADC Berlin
ID
845099
Dates
20 Feb 2017 - 22 Feb 2017
Location
Berlin, Germany
Contact
Jenny Barlow;     Phone: [+1 212 537 5898];     Email: info@hansonwade.com
Topics
Antibody drug conjugates, Antibody-drug conjugates, ADCs/ADC
Related subject(s)
2.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811327
Dates
20 Feb 2017 - 22 Feb 2017
Location
Baltimore, United States
Abstract
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Contact
James Martin;     Phone: [1-302-231-6959];     Email: Vaccines@madrige.com
Topics
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
3.
 
12th Annual Biomarkers Congress
ID
839687
Dates
21 Feb 2017 - 22 Feb 2017
Location
Manchester, United Kingdom
Abstract
Oxford Global is proud to present its 12th Annual Biomarkers Congress taking place on the 21-22 February 2017 in Manchester. Our renowned congress will bring together over 300 attendees, speakers and vendor companies from pharmaceutical and biotechnology companies as well as academia.

In line with the current industry trends, the flagship event this year focuses on the discovery, development and clinical development of biomarkers in Autoimmune, Immuno-oncology, Neuroscience, Oncology as well as Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome. Our expert speakers will also cover innovations in Biomarker research such as imaging biomarkers and assay development, big data challenges in biomarker research, new advances in biomarker technologies and platforms; insights into the human proteome atlas, population genetics, systems biology and their implications in Biomarker development. Do not miss out on gaining insights on the role of biomarkers in clinical development, clinical trials and clinical diagnostics.

Contact
Danielle Dalby;     Phone: [+44 1865248455];     Email: d.dalby@oxfordglobal.co.uk
Topics
Clinical development, clinical trials, clinical diagnostics, innovative biology, microRNA’s, CTCs, liquid biopsies and free circulating RNA & DNA.
Related subject(s)
4.
 
DDRI — 3rd Drug Discovery Re-Invented (Emerging Role of Biotechs, Academics and Non-Profits)
ID
842951
Dates
21 Feb 2017 - 24 Feb 2017
Location
Cancun, Mexico
Contact
Jack Peters;     Phone: [01638 724137];     Email: jack@fusion-conferences.com
Topics
drugs, drug, drug discovery, pharma, pharmacology, research, pipelines, government, academic, non-profits, biotech, pharmaceutical, innovation, natural products, drug development, structure, modeling, approaches
5.
 
Spotlight on Post Market Surveillance - By AtoZ Compliance
ID
879227
Start date
23 Feb 2017
Location
Webinar, United States
Abstract
This webinar will discuss the essentials of Post Market Surveillance, how you can develop your capabilities and how PMS can provide you with important information to improve your device, better service your customers, and reduce the risk of adverse events.

Post Market Surveillance (PMS) is the practice and system of monitoring the safety awareness training of a medical device after it has been released on the market.

It relies on several foundations including unique device identifiers (UDI), electronic health records and medical device reporting, device registries, and advance methods for evidence generation, data analysis and vigilance awareness training. It is a system that continues to develop and improve.

Contact
AtoZ Compliance;     Phone: [8444141400];     Email: referrals@atozcompliance.com
Topics
pharmacovigilance training online, safety awareness training, vigilance awareness training, Post Market Surveillance and Vigilance Webinar
6.
 
Pharma Outsourcing & Partnership 2017 Europe
ID
873396
Dates
23 Feb 2017 - 24 Feb 2017
Location
London, United Kingdom
Abstract
The global pharmaceutical industry is currently experiencing dynamic changes. Due to the high pressure of containing fixed costs all drug companies are reducing their internal capacities in R&D, marketing, manufacturing etc. in order to increase their outsourcing. Pharmaceutical companies big or small rely mainly on outsourcing service providers now more than ever to help solve problems, fulfil their tasks and improve efficiency and productivity. Thus it is crucial to create partnership opportunities to serve their individual needs. The two-day Pharma Outsourcing & Partnership Global Congress 2017 Europe will provide a unique platform for the convergence of stakeholders in the industry to interact, discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals and non-profit organizations as well as regional and local service providers to discuss and share on the outsourcing and partnership strategies, challenges and opportunities, global collaboration and the future of pharma outsourcing and partnership.
Contact
Jocelyn Raguindin;     Phone: [02035671321];     Email: acarabeti@paradigmglobalevents.com
Topics
Accountable Partnership, UK Homecare Market, Pharma Market, Contract Giver vs. Contract Acceptor, Ideal Strategic Partnership, Partnership outside Europe, Clinical Trials, Risk of Outsourcing, CMC Development, IND Filing, Anti-Counterfeiting tactics, Patent Law, Multifaceted Approach Towards Product Lifecycle Stability, Biopharmaceutical and Biomedical Charity Sectors, Global Healthcare Budgets, Competitive Landscape of Outsourcing, Growth into the Emerging Markets, Pharma outsourcing and partnership strategies, Biggest challenges and opportunities in pharma outsourcing and partnership, Vendor relationship management, Changes in outsourcing and partnership, Legal and Regulatory issues, Overcoming outsourcing risks and counterfeiting, Global collaboration, Partnership between pharma companies and CRO industries, The future of pharma outsourcing and partnership
7.
 
2nd Annual Lyotalk 2017 Asia — Pacific Largest conference in Freeze drying / Lyophilization
ID
852246
Dates
23 Feb 2017 - 24 Feb 2017
Location
HYDERABAD, India
Abstract
The event covers a wide spectrum from formulation, Development, Production, manufacturing and regulatory affairs topics such formulation strategies, Scale-up, cycle development & optimization, Regulatory compliance, Quality by Design (QbD) , PAT process design, Ice Nucleation, Case studies & troubleshooting, New developments in freeze drying, Process development for generics, proteins, biologics and vaccines.
Contact
Linda Clark;     Phone: [+912265344333];     Email: linda.clark@biotrains.com
Topics
The main topics will include • Formulation strategies • Scale-up, cycle development & optimization • Regulatory compliance • Quality by Design (QbD) • PAT process design, • Ice Nucleation • Case studies & troubleshooting • New developments in freeze drying • Process development for generics, proteins, biologics and vaccines.
8.
 
Frontiers in Cancer Immunotherapy
ID
824469
Dates
27 Feb 2017 - 28 Feb 2017
Location
New York, NY, United States
Abstract
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Topics
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
Related subject(s)
9.
 
Disposable Solutions for Biomanufacturing
ID
859593
Dates
27 Feb 2017 - 01 Mar 2017
Location
Munich, Germany
Abstract
By 2021 the knowledge and application of Single Use Systems will equal and even exceed that of Stainless Steel today. Where Disposable products and Single Use Technologies are becoming more widely used that ever before, this revolution has led to more questions than answers. In 2017, the 9th Annual event will bring you presentations from the main regulatory organisations plus panel discussions and case studies covering all aspects of disposables. Hear how to tackle all challenges from Particulates, Extractables and Leachables, System integrity, Implementation and more. This is the ONLY event that focuses on Single Use Technologies in biomanufacturing. For all your single use system questions, Disposable Solutions for Biomanufacturing Europe 2017 has the answers!
Contact
Rumina Akther;     Phone: [+44 (0)207 036 1300];     Email: enquire@iqpc.co.uk
Topics
Single use systems, SUS, disposables, bioreactors, standardization, CMO, Good Manufacturing Practice, GMP facility, extractables and leachables, BPOG, BPSA
10.
 
Chemical Development & Scale-Up in the Fine Chemical & Pharmaceutical Industries
ID
858655
Dates
01 Mar 2017 - 03 Mar 2017
Location
Pasadena, California, United States
11.
 
Seminar on the DHF, Technical File and Design Dossier - Similarities, Differences and the Future
ID
857590
Dates
02 Mar 2017 - 03 Mar 2017
Location
Las Vegas, NV, United States
Contact
Event Manager;     Phone: [(800) 447-9407];     Email: support@globalcompliancepanel.com
Topics
The Design History File, Device History Record, The Device Master Record, EU’s Medical Device Directive, Technical File Design Dossier, U.S. FDA’s DHF, FDA Compliance, FDA Regulations, Risk Analysis, Risk Management
12.
 
FDA's Regulation of Regenerative Medicine including Stem Cell Treatments, Tissue Engineering and Gene Therapies
ID
876829
Dates
02 Mar 2017 - 03 Mar 2017
Location
Boston, United States
Abstract
Stem cells harness the power to differentiate into numerous cells upon stimulation. This has led to their wide exploration across all of medicine, including high risk diseases. Of course, significant scientific breakthroughs in the use of stem cells to prevent, diagnose, and treat numerous diseases has caused numerous start-up companies to form. Despite, such promise, the FDA has yet to approve stem cell therapies for a wide range of diseases, except cord blood-derived hematopoietic progenitor cells for certain indications. This tutorial will provide an historical context for the use of stem cells in medicine, where the field has been and where it is going. It will also provide the few examples of FDA approved use of stem cells in medicine and what is needed for the field to progress. For example, in 2006, the U.S. FDA implemented regulations governing the use of human cells, tissues, and cellular and tissue-based products in humans including bone, ligament, skin, dura mater, stem cells, cartilage cells, and various other cellular and tissue-based products. Currently, there is an ongoing debate in industry on how such therapies should be regulated, in particular by the FDA or under the practice of medicine, under federal law or state law, and as drugs or simply biologics.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Regenerative medicine regulations, Stem Cell Treatments, biomaterials, FDA regulates regenerative treatments and therapies, good manufacturing
13.
 
Understanding the FDA's Regulation of HCT/Ps and Successful Product Development Strategies
ID
876773
Dates
02 Mar 2017 - 03 Mar 2017
Location
Boston, United States
Abstract
In 1997, the FDA proposed a comprehensive regulatory program for Human Cells, Tissues and Cellular- and Tissue-Based Products (HCT/Ps) outlining the registration and listing procedures for HCT/Ps. This program also differentiates between HCT/Ps that will be regulated via the traditional pathway and those that will undergo approval as new drugs, biologics or devices. In this seminar, we'll discuss the historical context for the use of HCT/Ps in medicine as well as how the HCT/P market is evolving. You will be shown examples of the FDA-approved use of HCT/Ps and what is required for successful product development. This course will also provide an overview of the health authority regulating HCT/Ps, discuss the regulations that govern HCT/Ps, discuss potential product development strategies and provide an overview of product development in the United States.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA regulatory oversight of HCT/Ps, tissue reference group, approval process, good tissue practice, good manufacturing practice, quality system regulations
14.
 
Keystone Symposia - Kinases: Next-Generation Insights and Approaches
ID
825311
Dates
05 Mar 2017 - 09 Mar 2017
Location
Breckenridge, Colorado, United States
Abstract
Decades of both basic and applied research have unequivocally established the importance the kinase family of phosphotransferase enzymes in virtually every aspect of organismal homeostasis. From the initial characterization of ATP-dependent phosphorylation in the liver by Gene Kennedy in 1954, our understanding of the family has grown from the diverse perspectives of enzymology, biochemistry, biophysics, structural biology, genetics, cellular biology, pharmacology and physiology. Importantly, these advancements have yielded transformative therapeutic approaches to disease, most notably in the field of cancer where kinase inhibition is helping to fulfill the promise of precision medicine. Yet even today, our perspectives on the complexity of this class of enzymes continues to evolve, and many of the most exciting advancements in the field are being made by applying modern-day insights and technological approaches to the diverse roles the enzymes can play in health and human disease. This meeting will be devoted to exploring this innovative leading edge of kinase research, and will bring together leading researchers from academic, clinical and pharmaceutical settings to explore and define the new horizons in the field of kinase biology.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Kinases, Drug Discovery, Kinase Signaling, Kinase Inhibitor
15.
 
BB17 — 3rd Biologics & Biosimilars Congress
ID
855022
Dates
06 Mar 2017 - 07 Mar 2017
Location
Berlin, Germany
Abstract
This internationally respected congress is the networking meeting for those working in all areas of protein, antibody & biosimilar research. Executive panels and roundtables will foster discussion on the direction of the field, and the approaches required to ensure that the industry continues to flourish.
Contact
Jane Williams;     Phone: [01865 849841];     Email: jane@globalengage.co.uk
Topics
Life Sciences/Biology, Health Sciences, Pharma
Related subject(s)
16.
 
Pharmacodynamics, Biomarkers and Personalised Therapy
ID
828761
Dates
06 Mar 2017 - 10 Mar 2017
Location
Oxford, United Kingdom
Abstract
The Pharmacodynamics, Biomarkers and Personalised Therapy course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the week will be led by Dr Elaine Johnstone, Senior Research Fellow at the University of Oxford, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists, as well as a practical visit to one of Oxford's research laboratories.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
17.
 
Recunnect Ltd — 3rd Anti-Counterfeiting Pharma Conference 2017
ID
870603
Dates
07 Mar 2017 - 08 Mar 2017
Location
London, United Kingdom
Abstract
We welcome you to be a part of Recunnect’s 3nd Anti-Counterfeiting Pharma Conference 2017 showcasing the anti-counterfeiting strategies for a better informed decision making. The aim is to foster discussion on how to tackle counterfeiting and improve patient safety. Gain the best insight into the most pressing challenges through practical advice on streamlining procedures and practices in the industry.
Contact
Sarika Sareen;     Phone: [2071129183];     Email: marketing@recunnect.net
Topics
Drug, pharma, health, medicines,
18.
 
The A to Z's of Microbial Control, Monitoring and Validation of Water Systems for Pharmaceuticals, Biologics, Medical Devices, Cosmetics, and Personal Care Products
ID
876889
Dates
08 Mar 2017 - 09 Mar 2017
Location
San Francisco, United States
Abstract
All facilities manufacturing pharmaceuticals, biologics, medical devices, cosmetics, and personal care products are likely to have high purity water systems. In spite of this purity, microorganisms can flourish within these systems and lead to undesirable contamination of facility processes and their products. Of all the individuals at the facility, it is site’s microbiologists who should understand the microorganisms in water systems and how best to monitor and control them. Sadly, this is often not the case due to the lack of familiarity with biofilm and its impact on water system sampling, testing, sanitization, and routine maintenance. This lack of understanding of microbial control often leads to poor system designs, poor system sampling, poor system maintenance and poor sanitization practices, and as a result, ongoing microbial problems with the water.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Pharmaceutical water systems seminar, water system compliance seminar, water system microbial control, water system microbial monitoring, water system validation
19.
 
Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices
ID
876768
Dates
09 Mar 2017 - 10 Mar 2017
Location
San Francisco, United States
Abstract
Federal regulation of the advertising and promotion of pharmaceuticals and medical devices reflects an aggressive attitude on the part of the regulators that demands, in turn, that industry be keenly aware of the legal and regulatory duties, as well as key recent trends in enforcement activities by the Federal Government. This course will explore in detail what FDA requires of drug and device firms as well as recent current hot buttons in FDA enforcement activity for the advertising arena.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA training seminar, FTC advertising seminar, advertising drugs, advertising medical devices, promotion drugs, promoting medical devices
20.
 
FDA's New Import Program for 2017 - Strict Precision
ID
876848
Dates
09 Mar 2017 - 10 Mar 2017
Location
Orlando, United States
Abstract
The FDA continues to change its import program to better manage new problems and to use new procedures to make the whole process easier. The FDA and U.S. Customs and Border Protection (CBP) are relying more and more on computer programs to expedite the import process. When and how you use these programs can make a big difference in the net profit derived from even a single shipment. The new Voluntary Qualified Importer Program (VQIP) is one such example. Another example is CBP’s and FDA’s implementation of the Automated Commercial Environment (ACE) program became mandatory for importers in 2016. If you fail to correctly use new import procedures and programs, you will be operating under an expensive disadvantage.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA import regulations, FDA’s import legal requirements, U.S. Customs and Border Protection, CBP requirements, FDA warning letter, FDA import program
21.
 
Essentials Of USP Microbiology - Reading Between the Lines of the USP General and Information Microbiology Chapters
ID
876872
Dates
09 Mar 2017 - 10 Mar 2017
Location
San Francisco, United States
Abstract
Learn essentials of USP microbiology - reading between the lines of the USP general and information microbiology chapters. Explore Form FDA 483s and Warning Letters for microbiological applications.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
USP Microbiology, USP microbiology chapters, USP general, USP General Chapter Changes, USP Chapters, USP document
22.
 
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions
ID
876821
Dates
13 Mar 2017 - 14 Mar 2017
Location
San Francisco, United States
Abstract
Raw material requirements in a cGMP environment are often overlooked as a company develops new products. Depending on the product being developed, e.g., tablets and capsules vs. biotechnology products, as few as fifteen to twenty or as many as sixty raw materials need to be sourced before the process can be moved from initiation through completion.Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Raw material requirements in a cgmp environment training, compendial and non-compendial testing, ASQ on sample size, ICH Q9, health canada requirements
23.
 
Pharmaceutica 2017 — 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
833055
Dates
13 Mar 2017 - 15 Mar 2017
Location
London, United Kingdom
Abstract
Pharmaceutica 2017 provides the perfect platform for just this as an interactive and engaging 3-day event: unique in format, content, networking and engagement. The event brings together truly innovative thinkers who are leading the way through trialing new disruptive solutions and rethinking the conventional formulation and delivery mind-set and will help you to better understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set and how innovative scientific techniques, emerging technologies and innovative devices can transform formulation and drug delivery.
Contact
Renaldo Howell;     Phone: [+1 702 508 5200];     Email: renaldohowell179@gmail.com
Topics
Pharmaceutics, Drug Delivery, Targeted Drug Delivery, Formulation, Pharmaceutical nanotechnology, nanomedicine, smart drug delivery
24.
 
Health Economics for Non-Health-Economists
ID
834352
Dates
16 Mar 2017 - 17 Mar 2017
Location
Brussels, Belgium
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
25.
 
Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)
ID
876788
Dates
16 Mar 2017 - 17 Mar 2017
Location
San Diego, United States
Abstract
Today, many companies operate on an outsourcing model. This is very common for companies who are evolving from being mainly development-focused to a point where they are entering latter stages of Phase 2 or Phase 3 clinical trials, and plan to have a product ready for market approval in the coming months. Most such companies are small, and may not have deep expertise in QA and GMP compliance, relying on their partners to cover those areas. Companies who outsource the majority of operations through the use of Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs) and Contract Laboratories, however, remain responsible for the quality and compliance status of the products they send to the clinic or to the marketplace. Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
GMP compliance for virtual companies, contract manufacturing organizations (CMOs), contract research organizations (CROs), Contract Laboratories, quality agreement
26.
 
2nd Personalized Medicine Conference
ID
853065
Dates
17 Mar 2017 - 20 Mar 2017
Location
Cancun, United Kingdom
Abstract
Join us for the 2nd Personalized Medicine conference taking place from 17-20 March 2017 in Cancun, Mexico to discuss to discuss precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data. The personalized medicine space has been defined by recent regulatory approvals of targeted therapeutics in oncology and co-developed diagnostics used in patient selection. However, a broader view of personalized medicine encompasses other disease areas, newer therapeutic regimens, new therapeutic platforms and broad computational approaches. This conference will weave together many of these new approaches and their relevance to personalized medicine.
Contact
Laura Trundle;     Phone: [+44 (0) 1638724137];     Email: laura@fusion-conferences.com
Topics
precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data.
Related subject(s)
27.
 
Keystone Symposia - Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
ID
825235
Dates
19 Mar 2017 - 22 Mar 2017
Location
Tahoe City, California, United States
Abstract
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
sex, gender, metabolic homeostasis, diabetes, obesity, sex differences, estrogens, androgen, drug design, gender-specific medicine, metabolomics, genetics
Related subject(s)
28.
 
Keystone Symposia - Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology
ID
825230
Dates
19 Mar 2017 - 23 Mar 2017
Location
Whistler, British Columbia, Canada
Abstract
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
cancer immunology, cancer immunotherapy, immunosuppressive cells, tumor microenvironment, immune checkpoints, combinatorial approaches, cancer vaccines, inflammation, cellular engineering, nex-gen technologies
Related subject(s)
29.
 
ITOC4 — 4th ImmunoTherapy of Cancer Conference
ID
848820
Dates
20 Mar 2017 - 22 Mar 2017
Location
Prague, Czech Republic
Abstract
The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy. The fourth edition (ITOC4) will take place on Prague, Czech Republic, from 20 to 22 March 2017. It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research. The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
Contact
Catherine Tomek (Congress Office);     Phone: [+431405138318];     Email: itoc@medacad.org
Topics
Preclinical models, Co-stimulatory agonists and co-inhibitory antagonists, Immunogenomics, Therapeutic modulation of immune checkpoints, Combination therapy, Anti-cancer vaccines, Engineered T-cell therapy, Monitoring of immunotherapy
Related subject(s)
30.
 
8th Annual Biotherapeutics Analytical Summit
ID
829849
Dates
20 Mar 2017 - 23 Mar 2017
Location
Bethesda, United States
Abstract
Today’s complex biologics formats and ever increasing regulatory demands necessitates that companies come up with the most efficient, accurate and robust analytical methods to characterize a molecule; find the most effective tools to assess the molecule’s physico-chemical properties to optimize its druggability and developability, and to ensure that the end product is consistently safe and efficacious when comparing between batches or between biosimilars and innovators. When it comes to batch-to-batch variation, as the saying goes, “process is the product” – process analytics and quality control are thus of biggest concern to manufacturers and regulators alike.
Contact
Bethany Gray;     Phone: [781-972-5400];     Email: chi@healthtech.com
31.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858686
Dates
21 Mar 2017 - 23 Mar 2017
Location
Nice , France
32.
 
CMC Documentation & Post-Approval Changes/Variations
ID
854532
Dates
22 Mar 2017 - 23 Mar 2017
Location
Frankfurt, NH Frankfurt Niederrad, Germany
Abstract
Do you work in regulatory affairs/CMC or quality assurance? Then you shouldn’t miss out on this event. This conference will address very practical questions and provide strategic information on future CMC trends. Join the in-depth discussion on new developments, including: requirements for drug substance and drug product, elemental impurities and stability, ASMF worksharing, GMP inspection and QP declaration, quality documentation of IMPs, quality risk management, management of post-approval CMC changes and much more.
Contact
Laura Vogelmann;     Phone: [+49 6221 500-655];     Email: l.vogelmann@forum-institut.de
Topics
quality management, regulatory affairs, vigilance, drug substance and drug product in Module 3, how to implement ICH Q3D?, ASMF worksharing, QP declaration and GMP inspection, post-approval change management, CMC part of the IMPD
33.
 
Root Cause Analysis and CAPA using 8-D Problem Solving Method
ID
876919
Dates
22 Mar 2017 - 23 Mar 2017
Location
Boston, United States
Abstract
Errors and defects are a problem in virtually every industry. The goal of defect-free/error-free product or service delivery is the aim of every company. However, in order to eliminate defects or errors permanently, you must use a disciplined approach in order to ensure that the problem does not recur. One of the most widely-used tools is the 8 Disciplines (8D) methodology. 8D requires you to identify and fix the problem immediately (put a bandaid on it) while identifying the Root Cause(s), and take steps to address the problem in the short term as well as in the long term (permanent fix).Note: Use coupon code < NB5SQH8N > and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
8-D Reporting, Reporting and Problem-Solving Technique, Root Cause Analysis, 8 Disciplines (8D) method, 8D framework, 8D technique, Root Cause Analysis (RCA)
34.
 
CSS 2017 — Cool Supply System & Solutions 400+ 6th Annual Meeting 2017
ID
854213
Dates
23 Mar 2017 - 24 Mar 2017
Location
Brussels, Belgium
Abstract
Over 400 attendees at the GDP Brussels Cool Chain conference, 6th annual meeting time and temperature pharma controlled logistics.
Contact
Jessica Dobson;     Phone: [+44 (0) 207 096 1152];     Email: Jessica.dosbson@businessdialogue.net
Topics
time and temperature, drug sensitive logistics, thermal packaging passive active, pharmaceutical logistics, logistics in pharmaceutical industry, reverse logistics in pharmaceutical industry, pharma distribution, pharma transport, cool chain logistics, European Cool chain conference 2017 Frankfurt Cool chain conference, IQPC Arena Cool chain conference, Brussels Cool Chain 2017, CSS 2017, Pharmaceutical supply chain conference, Drug Distribution, Last mile Movianto, Temperature controlled shipment, Pharma shippers Validation, Transport Pharma validation, Pharma logistics Brussels Airport, IATA CEIV Pharma Handling Validate, Good Distribution Practice Event, Pharma EU GDP conference, GDP quality system management, management review and monitoring of medicinal logistics, Pharma logistics quality risk management, the role of qualified person, validation of containers, qualification of storage or thermal mapping, Pharma 3pl, falsified medicinal products, drug integrity, Cool Chain Europe 2017
35.
 
Managing Your FDA Inspection: Before, During and After
ID
876742
Dates
23 Mar 2017 - 24 Mar 2017
Location
Chicago, United States
Abstract
FDA inspects many different kinds of firms. If the FDA regulates your product, they can show up at your lobby and say, “I am here to conduct an inspection.” What do you do? What have you done to prepare for an inspection? How do you deal with the investigator, including their personality? The scary part is having to explain the error of your ways to the FDA and above all, managing an administrative action, e.g., Warning Letter or Import Alert, or a legal action, e.g., civil money penalties, seizure, injunction or prosecution. This course will help you need to know and what you should do to survive an FDA inspection with the least possible pain.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA inspection seminar, FDA inspection, FDA 483, FDA warning letter, FDA investigator, FDA law, Regulatory Sanctions used by FDA, Prohibited Acts
36.
 
Creating FDA Compliant SOPs — FDA Compliant SOPs for Regulated Industry: How to Create High Quality SOPs that Your Team and FDA Auditors Will Love
ID
879342
Dates
23 Mar 2017 - 24 Mar 2017
Location
Boston, United States
Abstract
SOP deficiencies are one of the top 5 findings in FDA audits. The entire Quality Management System (QMS) of an organization could be severely compromised due to SOP defects. Formal written Standard Operating Procedures (SOPs) are required both by the FDA and EMA. Almost every deficiency identified in FDA’s 483s and Warning Letters can be traced back to deficiencies in SOPs at an organization. SOPs are often inadequate, miss important elements, do not contain important tools to increase compliance with the SOPs and, many times, are hard for the personnel who follow them to understand. This workshop is applicable to all FDA-regulated organizations: clinical trials, manufacturing, advertisement, marketing, regulatory affairs, auditing, and laboratory testing.
Contact
Peter Brown;     Phone: [+1 410 501 5777];     Email: pbrown@fdamap.com
Topics
FDA SOP, FDA Compliance, FDA Audit, FDA Inspection, FDA Regulations, FDA 483, FDA Warning Letters, Standard Operating Procedures
37.
 
Keystone Symposia - HIV Vaccines
ID
825203
Dates
26 Mar 2017 - 30 Mar 2017
Location
Steamboat Springs, Colorado, United States
Abstract
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Related subject(s)
38.
 
Drug Discovery 2017 — Drug Discovery 2017
ID
853294
Dates
27 Mar 2017 - 28 Mar 2017
Location
London, United Kingdom
Abstract
The conference aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. Highlights include: discussions on the use of CRISPR/Cas9 Technology in target discovery, hit finding and translational studies; optimising the success of phenotyping screening; exploring whether translational medicine is capable of increasing success rate in pharma; insights into receptor activation from agonist and antagonist structures; and applications of enabling chemistry technology to the acceleration of the drug discovery process. Speakers include Sanofi, Takeda, AstraZeneca, Merck Serono, Novartis, AbbVie, GSK, Johnson & Johnson, UCB Pharma, Eli Lilly & Co and more. Register at http://www.drug-discovery.co.uk/coms
Contact
Honey de Gracia;     Email: hdegracia@smi-online.co.uk
Topics
drug discovery, drug development, stem cells, precise-genome editing, CRISPR/Cas9, phenotypic screening, translational medicine, receptor activation, agonist structures, drug design, computer aided drug design, fragment based drug design, SBDD, FBDD, CADD
39.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864021
Dates
29 Mar 2017 - 31 Mar 2017
Location
London, United Kingdom
40.
 
Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)
ID
876866
Dates
30 Mar 2017 - 31 Mar 2017
Location
Tampa, United States
Abstract
The globalization of the pharmaceutical supply chain has led increased us of Contract Manufacturing Organizations (CMOs). The use of CMOs provides many benefits; however, it can present unique compliance risks, particularly since the operations are not in your facility and therefore not under your direct control. The compliance risks are highlighted by FDA Warning Letter trends, the majority of which are related to serious compliance and data integrity issues at foreign CMO sites.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
contract manufacturing pharmaceutical, CMO Oversight in Pharma Industry, CMO compliance, CMO business model, CMO Qualification Audit
41.
 
Understanding the Statistical Considerations for Quantitative ICH Guidelines
ID
876928
Dates
30 Mar 2017 - 31 Mar 2017
Location
Orlando, United States
Abstract
This course is designed to introduce to individuals the understanding and interpretation of the statistical concepts with reference to certain quantitative ICH Guidelines that apply across laboratory (drug development) and clinical development (drug/device) procedures such as analytical methods in validation and acceptance criteria in calibration procedures, risk management and process monitoring as well as dealing with uncertainties and other relevant issues. It is not a course in statistics but introduces the participant to a hands on approach to the statistical techniques one uses, how they are applied and reasonably interpreted and understood. One will address the various challenges facing pharmaceutical and biotechnology companies when it comes to quantifying results in a meaningful interpretable manner through tabulations and graphical presentations. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Statistical considerations for quantitative ich guidelines training, quantitative measurement procedures, sensitivity of the sample size
42.
 
ICBMB 2017 International Conference on Biochemistry and Molecular Biology 3-5 April 2017, Munich, Germany
ID
853117
Dates
03 Apr 2017 - 05 Apr 2017
Location
Munich, Germany
Contact
Andrea Berg;     Phone: [adeo.office@gmail.com];     Email: adeo.office@gmail.com
Topics
biology, biochemistry, molecular biology
43.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858729
Dates
04 Apr 2017 - 06 Apr 2017
Location
Verona, Italy
44.
 
MESMAP-3 — The Third Mediterranean Symposium on Medicinal and Aromatic Plants
ID
811658
Dates
13 Apr 2017 - 16 Apr 2017
Location
Girne (Kyrenia), Cyprus, Turkey
Related subject(s)
Event website
45.
 
US GCP Fundamentals for Pharmaceutical and Biologic Companies
ID
876809
Dates
20 Apr 2017 - 21 Apr 2017
Location
San Francisco, United States
Abstract
Good Clinical Practice (GCP) is a term used to describe a collection of various FDA regulations that govern the conduct of clinical trials. It includes regulations which apply to Sponsors and Contract Research Organizations (CROs) who run the trials, the clinical trial sites and Investigators who conduct the research, the Institutional Review Boards (
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA GCP inspections, good clinical practices seminar, GCP compliance, clinical trial sites, IRBs, good manufacturing practice, GMP, FDA inspection management
46.
 
FDA Scrutiny of Promotion and Advertising Practices
ID
876816
Dates
20 Apr 2017 - 21 Apr 2017
Location
Tampa, United States
Abstract
If you go
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
fda's advertising and promotion requirements, fda regulations for labelling, fda warning letter, fda legal authority, ftc, mass media, doj, off label, fda guidance
47.
 
Pharma Tech 2017 — International Conference and Exhibition on Pharmaceutical Development and Technology
ID
828986
Dates
24 Apr 2017 - 26 Apr 2017
Location
Dubai, United Arab Emirates
Abstract
ConferenceSeries LLC is a renowned organization that organizes highly notable pharmaceutical conferences and healthcare conferences throughout the globe. ConferenceSeries LLC invites all the participants from all over the world to attend “International Conference and Exhibition on Pharmaceutical Development and Technology ”during April 24-26, 2017 Dubai, UAE.This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma Tech 2017 is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multibillion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll.
Contact
Mythrei Syria;     Phone: [+1-702-508-5200];     Email: pharmatech@pharmaceuticalconferences.com
Topics
Pharmaceutical Technology, Pharmaceutical Technology Conferences, Pharma Tech Meetings, Pharma Tech Symposiums, Pharma Tech Exhibitions, Pharma Tech 2017 Conferences, Pharma Tech Conferences Dubai, Pharma Tech meetings USA, Pharma Tech Conferences euro
48.
 
Pharma Strategic Alliance Management — 7th Annual Strategic Alliance Management for Pharma
ID
871383
Dates
24 Apr 2017 - 26 Apr 2017
Location
London, United Kingdom
Abstract
This marcus evans conference goes back to the fundamentals: how to structure the Alliance management internally, what are the responsibilities and roles of the Alliance function. With various types of collaborations, complex projects, it’s important for Alliance Management to be structured and to have the right tools available. We will also point out the value creation in the company and how evaluating alliances by measuring progress, bringing KPI and performance tools in the process. Structuring alliances is also to count on governance body and look at relations with steering committees, legal entities and contracts to effectively run alliances along their life cycle. The delegates will have the possibility to discuss, exchange and compare their methods but also meet various stakeholders of the life science panorama.
Contact
Constandinos Vinall;     Phone: [+357 22 849 380];     Email: ConstandinosV@marcusevanscy.com
Topics
Implement the best practices in managing alliances, Improve alliance capabilities on the full alliances portfolio, Define and document common understanding and expectations with partners, Develop a set of tools to measure performance and objectives’ alignment, Choose the right partner according to the strategy and needs, Set mutual trust and keep the relationship in good conditions, Expand Alliance management framework across the organisation, Cope with unsuccessful partnerships and termination processes
Event website
49.
 
Corvus Global Events — Digi-tech Pharma 2017
ID
850883
Dates
25 Apr 2017 - 26 Apr 2017
Location
London, United Kingdom
Abstract
Digital Pharma World 2017, will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. It will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of digital pharma. Also, to stay updated on the latest trends in digital, social media and mobile strategies required the overcome the obstructions in the transformation. This conference will allow IT leaders to share their technologies and strategies to help the pharma industries. The conference will offer opportunities to encourage partnerships and collaborations
Contact
Fazmina Fajjuu;     Phone: [+44 (0) 207 096 0786];     Email: fazmina@corvusglobalevents.com
Topics
Key Highlights of the conference: • Digitally enabled business models • Big data analytics and pharma • Internet of things and pharma • Translational Informatics • Policy changes required for ensuring smooth transition • Ensuring regulatory compliance during the transformation • Digital marketing trends • Integrating Multichannel marketing and closed loop marketing • Digitalization of R& D using Big Data and IoT • New smart devices in manufacturing and supply chain • Clinical trials and digital world • Data management • Tools and strategies to engage with HCPs and patients and to win their confidence • Encouraging a customer–centric approach at all levels • Unrealized innovative potentials of digital era that pharma needs to focus on . Attendees includes VPs, GMs, Directors, Heads and Managers of • Pharma sales and Marketing • E-marketing • Digital innovative strategic planning • Regulatory and pharmacovigilance • IT consultants • Clinical trials and data management • Translational informatics • Data storage and analysis • Contract outsourcing service providers • Multi-channel Management • Health care professionals • Health IT professionals
50.
 
PFS East Coast — Pre-Filled Syringes East Coast
ID
854608
Dates
26 Apr 2017 - 27 Apr 2017
Location
Boston, United Kingdom
Abstract
Building on the success of previous sell-out shows, SMi Group is delighted to announce the return of the 4th annual conference and exhibition: Pre-Filled Syringes - East Coast, taking place on April 26th – 27th 2017 in Boston, Massachusetts, USA. Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS market professionals, providing a unique platform to discuss the latest innovations and developments in pre-filled syringes; as well as hone in on industry challenges and regulatory compliance. Featured speakers include AbbVie, Shire, Amgen, Eli Lilly, Allergan, Janssen, Merck and more!
Contact
Teri Arri;     Phone: [2078276000];     Email: tarri@smi-online.co.uk
Topics
prefilled syringe, pre-filled syringe, autoinjector, human factors, device development, innovation, strategy, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, combination products, lyophilisation, freeze drying, injectable, injectable devices, syringe, extractables and leachables, E&L, PFS, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, device development, human factors, manufacturing, device technology, medical device, parenteral drug, plastic, qbd, drug delivery
Related subject(s)
51.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864075
Dates
26 Apr 2017 - 28 Apr 2017
Location
Berlin, Germany
52.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825375
Dates
01 May 2017 - 04 May 2017
Location
Estes Park, Colorado, United States
Abstract
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Related subject(s)
53.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864118
Dates
03 May 2017 - 05 May 2017
Location
Dublin , Ireland
54.
 
Navigating the Maze for Post-Market Compliance -- Complaint Handling, MDRs, Recalls and Proposed Guidance on FDA Risk Benefits
ID
878159
Dates
04 May 2017 - 05 May 2017
Location
Pittsburgh, United States
Abstract
This interactive one and a half day course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief, who has more than 36 years’ experience with the FDA will provide the participants tools to minimize risk of regulatory enforcement actions. During the seminar, Ms. Hoffman will explain proper handling of complaints reportable or non-reportable, product complaint handling and documentation, how and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall. She will also discuss how to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
medical device recalls seminar, medical device regulations seminar, medical device reporting, medical device complaint management, medical device complaint handling
55.
 
3rd Annual Formulation & Drug Delivery Congress
ID
859574
Dates
08 May 2017 - 09 May 2017
Location
London, United Kingdom
Abstract
Oxford Global are proud to present our 2017 3rd Annual Formulation & Drug Delivery Congress, taking place on 8 – 9 May 2017 in May in London, UK. Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will have the opportunity to discuss over 40 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery. Including 4 interactive streams: Large Molecule Drug Formulation; Small Molecule Drug Delivery; Small Molecule Drug Formulation and Large Molecule Drug Delivery.
Contact
Guillaume Alonso;     Phone: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
drug delivery, drug formulation, small molecule, large molecule
Related subject(s)
56.
 
2nd Annual Inhalation & Respiratory Drug Delivery Congress
ID
873447
Dates
08 May 2017 - 09 May 2017
Location
London, United Kingdom
Abstract
Oxford Global are proud to present our 2017 2nd Annual Inhalation & Respiratory Drug Delivery Congress, taking place on 8 – 9 May 2017 in London, UK. Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will have the opportunity to discuss over 40 presentations and case studies focused on the key issues in inhalation and respiratory drug delivery. Including 4 interactive streams:Development & Formulation of Inhaled Therapies and Inhalation Devices & Analytics. Download Agenda Now: http://bit.ly/1NGMsPG. For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.
Contact
Guillaume Alonso;     Phone: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
inhalation drug delivery, respiratory drug delivery, inhalation devices, inhaled therapies
57.
 
Pharmaceutical Freeze Drying Technology
ID
877241
Dates
08 May 2017 - 09 May 2017
Location
London, United Kingdom
Abstract
Robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining product quality and biological stability. Innovation and efficiency is requested at every level making Pharmaceutical Freeze Drying Technology the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to growing manufacturing demands.

Gathering a room of Senior Scientists and Heads of Pharmaceutical Engineering, the 5th annual show provides an ideal forum to discuss the latest advancements in pharmaceutical lyophilisation, welcoming regulatory guidance from the NIBSC-MHRA and expertise from the likes of Sanofi, Boehringer Ingelheim, Roche, Novo Nordisk and more!

Contact
Teri Arri;     Phone: [2078276000];     Email: tarri@smi-online.co.uk
Topics
lyophilisation, quality by design, freeze drying, scale-up, validation, spray drying, Process Analytical Techniques, PAT, robustness, stability, delivery, optimisation, protein stabilisation, design strategies, maintenance, automatic loading and unloading, lyophilization, qbd, protein, optimization, aseptic, fill/finish, temperature, drying, powder, nucleation, sterilization, injectables, thaw, storage, crystallization, formulation, parenteral, QBD, manufacturing
Related subject(s)
58.
 
Adverse Drug Reactions, Drug Interactions and Pharmacovigilance
ID
828804
Dates
08 May 2017 - 12 May 2017
Location
Oxford, United Kingdom
Abstract
The Adverse Drug Reactions, Drug Interactions and Pharmacovigilance course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Michael Theodorakis, Radcliffe Department of Medicine, University of Oxford, and will feature face-to-face lectures and tutorials from some of the country's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
59.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834357
Start date
09 May 2017
Location
Brussels, Belgium
Abstract
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
60.
 
E&L USA 2017 — Extractables & Leachables USA 2017
ID
854349
Dates
09 May 2017 - 11 May 2017
Location
Falls Church, VA, United States
Abstract
Extractables and leachables examination is continuously growing in importance. Given the current scruitny paid by governing bodies including the FDA and EMEA, understanding the best practice and guidelines to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.
Contact
Emma Nweton;     Phone: [+44 (0) 1372 802016];     Email: enewton@smithers.com
Topics
extractables, leachables, analytical chemistry, pharmaceuticals, drug development, drug delivery, regulations, quality assurance, single-use systems, risk assessments, packaging, drug packaging
61.
 
PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation
ID
878169
Dates
11 May 2017 - 12 May 2017
Location
San Francisco, United States
Abstract
The European Medicines Agency's (EMA) Guideline on good pharmacovigilance practices (GVP), Module IV requires that risk-based audits of the quality system be performed at regular intervals to assure that it complies with the established quality requirements and to determine its effectiveness. It includes audit of the pharmacovigilance system which is covered by the quality system. The GVP Modules are applicable to EU-based companies and any company marketing medicinal products on a global basis. The legally required risk based audit strategy shall cover all PV processes and tasks undertaken by or delegated to other departments, MAH affiliates, and third parties such as distributors, external service providers, partners (the PV Universe). The PV Audit Strategy Plan is used to prepare the PV audit program, i.e. annual PV Audit Schedule. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
PV Audit Strategy Planning, The European Medicines Agency's (EMA) Guideline, Good Pharmacovigilance Practices (GVP), risk-based audits, GVP Modules, PV Universe
62.
 
Orphan Drugs and Rare Diseases Europe 2017
ID
852632
Dates
15 May 2017 - 16 May 2017
Location
Berlin, Germany
Abstract
SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market.
Contact
Kyra Williams;     Email: kwilliams@smi-online.co.uk
Topics
Orphan Drugs, Rare Diseases, Market Access, Pricing and Reimbursement, Patient Recruitment
63.
 
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)
ID
878135
Dates
15 May 2017 - 16 May 2017
Location
Boston, United States
Abstract
The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manufacture of human and animal drugs and biological products, including Active Pharmaceutical Ingredients (APIs). These guidances align Process Validation activities with a product lifecycle concept and with existing FDA and EU guidances, including the FDA/International Conference on Harmonization (ICH), Guidance for Industry, Q8 (R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The lifecycle concept, new to these Guidances, link product and process development, qualification of the commercial manufacturing process, and maintenance of the process in a state of control during routine commercial production. These guidances also support process improvement and innovation through sound science and risk management. The new Process Validation Guideline/Practice incorporate elements of Process Validation as early as the Research and Development phase, and continues onward through Technology Transfer, into the Phase 1 IND Clinical Trial manufacturing phase, and ultimately into Phase 2 and 3, and then commercial manufacturing. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA Process Validation Guidance, EU Annex 15, Active Pharmaceutical Ingredients (APIs), International Conference on Harmonization (ICH)
64.
 
Gavin Conferences — International Conference on Pharmaceutical Drugs
ID
848217
Dates
15 May 2017 - 17 May 2017
Location
Dubai, United Arab Emirates
Abstract
Gavin Conferences invites participants from all over the world to attend “International Conference on Pharmaceutical Drugs” to be held on May 15-17, 2017 at Dubai, UAE. The conference is organized with the theme “Bridging the gap between Drugs and Disease Prevention” which includes keynote presentations from world class scientists and researchers, Oral talks, Poster presentations, B2B meetings and Exhibitions. World-renowned speakers, the most recent techniques and updates in the field of Pharmaceutics are hallmarks of this conference.
Contact
Daniel;     Phone: [6303970234];     Email: danielgavin456@gmail.com
Topics
Pharmaceutical Drug Development,  Drug Formulation, Evaluation, Drug Discovery, Drug Designing, Drug Delivery Systems, New Manufacturing technologies, Pharmaceutical Industry, Adverse Drug Reactions, Pharmaceutical Business
65.
 
MENA Cold Chain — 4th Annual MENA Pharmaceutical Cold Chain Forum
ID
870074
Dates
16 May 2017 - 17 May 2017
Location
Dubai, United Arab Emirates
Abstract
The MENA region continues to face its challenges as most temperature deviations occur during supply chain transportation. The pharmaceutical industry relies heavily on the airline industry for its speed and efficiency. Unfortunately, 57% of deviations happen at the airport premises. Temperature changes during transportation have been a serious threat to the integrity of the products. Shippers in the region are on a constant look out for service providers who can help them maintain the product integrity and efficacy during transportation.
Contact
MCI Dubai;     Phone: [97143116300];     Email: conferences@mci-group.com
Topics
Pharmaceutical
66.
 
Principles of Pharma Market Access in Europe
ID
834261
Dates
16 May 2017 - 17 May 2017
Location
Zurich, Switzerland
Abstract
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
67.
 
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC)
ID
878112
Dates
16 May 2017 - 17 May 2017
Location
Philadelphia, United States
Abstract
This interactive one-and-a-half-day seminar is intended to educate regulatory and quality professionals regarding the rather complicated regulations that distinguish Non-prescription Drugs from other products such as foods, cosmetics, dietary supplements and prescription drugs that sometimes contain the same ingredients. Recent FDA actions such as the banning of antibacterial soaps and ongoing programs that may impact manufacturers and private label distributors will be discussed. It will explain differences in the way homeopathic and conventional drugs are regulated and update participants on FDA’s application of GMP regulations to manufacturing low risk drugs that could be sold as cosmetics with the same ingredients, but different labeling. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Cosmeceuticals, dietary supplements, cosmetics, homeopathic OTCs, FDA regulations, FDA GMPS, good manufacturing practices, over the counter, low risk OTC drugs, warning letters, FDA enforcements actions, FDA marketing regulations
68.
 
CRISPR Summit
ID
877854
Dates
17 May 2017 - 18 May 2017
Location
London, United Kingdom
Abstract
There is no doubt about it, CRISPR is rapidly changing the way diseases are researched, and will soon revolutionize the way they are treated. However, challenges affecting the use of this technique is halting its overall progress and this summit is ready to address the key issues currently affecting CRISPR research.

Topics for debate will include all aspects of CRISPR, from the different techniques of delivering Cas9 to uncovering how to control the repair pathway. The summit will also be assessing the limitation of CRISPR technique and discover what key developments have allowed progress in understanding the unknown. Sessions on screening and bioinformatics will also be included to see how these tools have helped predict the outcome of the CRISPR/Cas9 system.

Whether you are already underway with using CRISPR in your research, or are considering implementing the technology, this conference is where you need to be in 2017!

Contact
Faith Arinaitwe;     Phone: [+44 (0)207 036 1300];     Email: enquire@iqpc.co.uk
Topics
CRIPSR, CAS 9, In vivo, Gene expression, Gene Editing
Related subject(s)
69.
 
Value Pricing for Market Access - The Fundamentals
ID
834366
Dates
18 May 2017 - 19 May 2017
Location
Zurich, Switzerland
Abstract
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
70.
 
Vaccines Global Congress 2017 Europe
ID
873331
Dates
18 May 2017 - 19 May 2017
Location
London, United Kingdom
Abstract
Paradigm Global Events is proud to present its Vaccines Global Congress 2017 Europe. Progress in virology, genetics, synthetic biology, and biotechnology has provided a new set of tools to approach current-day vaccinology, while increased understanding of human immunity and microbes has catalyzed unprecedented advances that can be adopted to improve public health. Despite continuing challenges, the collective effort of governments and nonprofit organizations to expand the utilization of effective vaccines throughout the world has grown.
Contact
Jocelyn Raguindin;     Phone: [02035671321];     Email: rmasseretti@paradigmglobalevents.com
Topics
Epitope, Protein based Vaccine, Vaccine manufacturing, Batch cultivations, Plant Biotechnology, Malaria, HIV, Dengue, Tubercolosis, Hepatitis, Pediatric Vaccines, Vectored Vaccines, Clarification of Vaccines, Aids Vaccines, Economics of Vaccine production, Vaccine Immunotherapy, Dendritic Cell Vaccines, Pancreatic Cancer, Zika Fever, Ebola Virus, Universal Flu Vaccine, TB Vaccines, Alzheimer's disease, Cervical Cancer, Latest developments on new adjuvant technologies and novel immunotherapies in the treatment of cancer and emerging viral diseases, Comprehensive insights on new technological developments in vaccine production, Regulatory approach and economic consideration on vaccine trials.
71.
 
Quality Control Laboratory Compliance - cGMPs and GLPs
ID
878141
Dates
18 May 2017 - 19 May 2017
Location
Philadelphia, United States
Abstract
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries - pharmaceuticals, biologics, medical devices, as well as foods and cosmetics - as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Quality Control Lab regulations, QC Lab regulations, FDA QC Lab requirements, FDA lab regulations, Good Laboratory Practices, GLP, cGMP, Current Good Manufacturing Practices
72.
 
HPAPI — Highly Potent Active Pharmaceutical Ingredients 2017
ID
854698
Dates
22 May 2017 - 23 May 2017
Location
London, United Kingdom
Abstract
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions.
Contact
Kyra Williams;     Email: kwilliams@smi-online.co.uk
Topics
API- Active Pharmaceutical Ingredients, Cytoxic, Potency, HA - Health Agency, PDE - Permitted Daily Exposure, Cross Contamination, Compound, Scale Up
Related subject(s)
73.
 
Biologistics World Korea 2017
ID
827142
Dates
23 May 2017 - 24 May 2017
Location
Seoul, South Korea
Abstract
Biologistics World Korea is the MOST Targeted event in Korea that focuses on supply chain management and logistics for biologics and vaccines. Located in Singapore, the prime logistics hub of Korea, the programme promises to bring together key opinion leaders, rising players and market experts to discuss, debate and brainstorm on the most pertinent issues affecting Korea’s logistics network within a global context!
Contact
Andrew Darwitan;     Phone: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
74.
 
Learning and Memory: Cellular and Molecular Mechanisms
ID
857977
Dates
28 May 2017 - 04 Jun 2017
Location
Siena, Italy
Abstract
Recent ground-breaking developments in neuroscience, such as optogenetics, in vivo 2-photon confocal microscopy, head mounted microscopes, powerful new developments in modeling, behavioral neuroscience approaches, and sophisticated brain imaging tools, have changed dramatically studies of memory. Most importantly, these developments have fostered interdisciplinary studies that led to integrated molecular, cellular, systems, cognitive and behavioral explanations of how memories are allocated, formed, consolidated, reconsolidated and retrieved. These studies have also led to mechanistic cross-disciplinary studies of memory disorders, which in some cases led to the development of targeted treatments that are changing how we imagine treating the considerable health burden associated with this large class of conditions.
Contact
Francesca Martini;     Phone: [+39.0577.146.0003];     Email: info@nsas.it
Related subject(s)
75.
 
Pre-Filled Syringes West Coast
ID
877349
Dates
05 Jun 2017 - 06 Jun 2017
Location
San Diego, United States
Abstract
SMi Group are thrilled to announce the return of Pre-Filled Syringes West Coast 2017 which arrives to California on June 5th & 6th.

Following on from sell-out shows in Europe and Boston, Pre-Filled Syringes West Coast will once again gather a global audience of medical device experts and PFS industry leaders to discuss new developments and showcase cutting edge advances, keeping you at the forefront of a booming industry. The competitive PFS market has sparked great improvements as devices strive for higher quality, safety, and patient satisfaction. Innovation and excellence is requested at every level making Pre-Filled Syringes West Coast the perfect platform to strengthen knowledge in key principles such as human factor engineering, manufacturing and complex biologics, whilst honing in on emerging trends for parenteral devices, including auto injectors, pens, pumps and smart devices. We will also be welcoming expertise from the likes of Nemera, Nipro PharmaPackaging, Terumo, Worrell, Zeon, Allergan, MedImmune, Xeris Pharmaceuticals, Amgen, Eli Lilly, Genentech, Ferring, Roche and more.

Contact
Teri Arri;     Phone: [+44 (0)20 7827 6000];     Email: tarri@smi-online.co.uk
Topics
prefilled syringe, pre-filled syringe, autoinjector, human factors, device development, innovation, strategy, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, combination products, lyophilisation, freeze drying, injectable, injectable devices, syringe, extractables and leachables, E&L, PFS, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, device development, human factors, manufacturing, device technology, medical device, parenteral drug, plastic, qbd, drug delivery, infusion, vial, cop, sterilization, clogging
76.
 
18th Annual Drug Discovery Summit
ID
845290
Dates
12 Jun 2017 - 13 Jun 2017
Location
Berlin, Germany
Abstract
This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field.
Contact
Guillaume Alonso;     Phone: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
drug discovery, screening, genomics, biotechnology, pharmaceutical, small molecule, large molecule, technologies
77.
 
ADMET — 12th annual ADMET
ID
873428
Dates
12 Jun 2017 - 13 Jun 2017
Location
London, United Kingdom
Abstract
SMi is delighted to announce the 12th annual ADMET conference returning to London in 2017! This event will be discussing new technologies, innovation and developments in the ADMET sector. ADMET technologies determine properties of a drug candidate in the preclinical stage of drug discovery, and poor ADMET properties are a major cause for a candidate to fail in drug development.
Contact
Kyra Williams;     Phone: [02078276012];     Email: kwilliams@smi-online.co.uk
Topics
Admet, Gentotoxic, In Vivio, In Vitro, In Silico, Assay, DMPK, DDI, Metabolites
78.
 
Pharma Engineering 2017 — International Conference on Pharmaceutical and Biomedical Engineering
ID
852677
Dates
12 Jun 2017 - 13 Jun 2017
Location
Taipei, Taiwan
Abstract
Conference Series LLC is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “International Conference on Pharmaceutical and Biomedical Engineering” (Pharma Engineering 2017) scheduled to be held during June 12-13, 2017 at Taipei, Taiwan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical and Biomedical Engineering.
Contact
Diya Sharan;     Phone: [7025085200];     Email: pharmaengineering@pharmaceuticalconferences.com
Topics
Pharmaceutical Engineering, Biomedical Engineering, Pharmaceutical Technology, Pharmaceutical Formulations, Drug delivery, Drug Discovery, Genetic Engineering, Tissue Engineering, Bio Imaging, Process Engineering, Pharmaceutical Process Technology Novel drug deliveryNanotechnology Engineering
79.
 
10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
831590
Dates
13 Jun 2017 - 15 Jun 2017
Location
London, United Kingdom
Contact
Renaldo Hawell;     Email: renaldohowell179@gmail.com
Topics
Pharmaceutics/Formulation/Drug Delivery/Vaccine/Novel Drug Delivery
80.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858752
Dates
13 Jun 2017 - 15 Jun 2017
Location
Edinburgh , United Kingdom
81.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858773
Dates
13 Jun 2017 - 15 Jun 2017
Location
Chicago, United States
82.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864106
Dates
14 Jun 2017 - 16 Jun 2017
Location
London, United Kingdom
83.
 
FASEB SRC — From Unfolded Proteins in the Endoplasmic Reticulum (ER) to Disease
ID
871033
Dates
18 Jun 2017 - 23 Jun 2017
Location
Saxtons River, VT, United States
Abstract
This SRC focuses on the endoplasmic reticulum (ER) and its functions. The purpose of the meeting is to merge recent developments in molecular biology, cell biology, genetics, and physiology aimed at unraveling the complexities of secretory protein folding, ER stress pathways, lipid signaling, and ER membrane biology, and how failure of these processes lead to pathologies and disease. This SRC will include talks from outstanding scientists, both invited and selected from poster abstracts. The meeting is known for its active discussions, not only during the presentation session, but also during the free afternoons, and especially during the poster sessions. Posters will remain on display during most of the conference and a selection will be advertised in oral poster pitches. The venue, Vermont Academy, is excellently suited for the mingling of junior and established scientists, which will be strengthened by meet-the-speaker sessions that allow discussions of both career issues and science.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
biochemistry, Pharmacology
Related subject(s)
84.
 
Health Economics for Non-Health-Economists
ID
834362
Dates
20 Jun 2017 - 21 Jun 2017
Location
Brussels, Belgium
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
85.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781802
Dates
20 Jun 2017 - 23 Jun 2017
Location
Albufeira, Portugal
Abstract
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Related subject(s)
86.
 
BPD 2017 — Bulgarian Pharmaceutical Days 2017
ID
878020
Dates
23 Jun 2017 - 25 Jun 2017
Location
Ruse, Bulgaria
Abstract
The Bulgarian Pharmaceutical Days (BPD) is a trademark of the Bulgarian Pharmaceutical Union (BPU). The tradition started back in 1996, and ever since the forum is held annually. From 2007 the event became popular under the trademark “Bulgarian Pharmaceutical Days”. In line with tradition, the event is associated with the celebration of Saint John's Eve, June 24, the Day of Pharmacists in Bulgaria. For the eleventh consecutive year, the 2017 edition of the Bulgarian Pharmaceutical Days will allow you to strengthen your networking with existing and new contacts, to share your experience and to discuss the most important and topical issues in pharmaceutical theory and practice. Over the years the forum was attended by a number of distinguished guests and presenters from the top legislative and executive levels of the Republic of Bulgaria, academia, the Pharmaceutical Group of the European Union, and professional associations of health professionals from this country and from other EU states alike.
Contact
Mariana Nedeva;     Phone: [+359 2 494 94 84];     Email: pharma@newevent.bg
Topics
Pharmaceutic
87.
 
16th Annual Medicinal & Pharmaceutical Sciences Congress (Med Pharma Congress)
ID
852270
Dates
03 Jul 2017 - 05 Jul 2017
Location
Kuala Lumpur, Malaysia
Abstract
Conference Series LLC invites all the participants across the globe to attend 16th Annual Medicinal & Pharmaceutical Sciences Congress during July 3-5, 2017 in Kuala Lumpur, Malaysia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Med Pharma Congress is a specially designed cluster Pharma conference. The main theme of this Pharma conferences is “Developing the Synergy between Pharmaceutics and Medicinal Chemistry to Deliver Better Drugs” which covers a wide range of critically important sessions.
Topics
Medicinal Chemistry • Pharmacology • Chromatographic Techniques for Drug Analysis • Synthetic Organic Chemistry • Bio Pharmaceuticals • Pharmacogenomics • Pharmacognosy and Phytochemistry • Pharmaceutical Toxicology • Industrial Pharmacy
Related subject(s)
88.
 
How to do Research on Therapeutic Interventions: Protocol Preparation
ID
828721
Dates
03 Jul 2017 - 07 Jul 2017
Location
Oxford, United Kingdom
Abstract
The How to do Research on Therapeutic Interventions: Protocol Preparation course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Grant D Vallance, Information Manager at the Oxford University Hospitals NHS Trust, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
89.
 
9th World Congress on BA/BE Studies and Biowaivers
ID
849730
Dates
17 Jul 2017 - 19 Jul 2017
Location
Melbourne, Australia
Abstract
Bioequivalence Congress is a 3-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.
Contact
Daisy Pearl;     Phone: [(702) 508-5200 Extn-8045];     Email: ba.beasia@pharmaceuticalconferences.org
Topics
drug research, generic drugs, bioequivalence, pharmacology, clinical pharmacology, bcs, biowaivers, pharmcodynamic studies, clinical trails, clinical research, FDA
90.
 
9th International Conference and Exhibition on Pharmacovigilance & Drug Safety
ID
869808
Dates
17 Jul 2017 - 19 Jul 2017
Location
Munich, United States
Contact
programe cordinator;     Phone: [702-508-5200];     Email: pharmacovigilance@pharmaceuticalconferences.org
Topics
Advanced Regulatory Compliance in Pharmacovigilance operations and innovations Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
91.
 
NanoPharma 2017 — 13th International Conference and Exhibition on Pharmaceutical Nanotechnology
ID
852381
Dates
24 Jul 2017 - 25 Jul 2017
Location
Rome, Italy
Abstract
Currently we are bringing forth “13th International Conference and Exhibition on Pharmaceutical Nanotechnology” (NanoPharma 2017) scheduled to be held during July 24-25, 2017 at Rome, Italy. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Drug delivery.
Contact
Angela Mathews;     Phone: [7025085200];     Email: nanopharma@pharmaceuticalconferences.org
Topics
drug delivery, nanoparticles, nanodrugs, nanomedicines, nanopharmaceuticals, pharmaceutical nanotechnology, liposomes, neosomes, erythrosomes
92.
 
Asia Pharma 2017 — 10th Asia-Pacific Pharma Congress
ID
827489
Dates
24 Jul 2017 - 26 Jul 2017
Location
Melbourne, Australia
Abstract
Asia Pharma 2017 is a perfect platform for scientists, decision-makers and students to come together, compare findings, and discuss the science of the future. Share your research with an engaged audience of your peers from around the globe; learn from scientific trail blazers who are designing more sustainable processes; find out how Pharmaceutical innovations are inspiring new businesses and product lines. Pharmaceutical sciences focus on the physiology and chemistry controlling drug therapeutic action in modern medicine. Often confused with pharmacy practice, pharmaceutics is distinct in its research and development emphasis, contributing important technologies and scientific bases for drug delivery to patients. Over half of newly discovered drug candidates cannot be commercialized without further drug delivery and formulation assistance. Researchers trained in pharmaceutics integrate a broad working knowledge of diverse scientific disciplines: from fundamental studies of drug physiochemical properties and bioactive molecules to mechanisms of various physiological processes that impact drug delivery to specific biological sites of action and, therefore, their therapeutic effectiveness. Increasing awareness of the complexity of the drug delivery process in living systems means that researchers in pharmaceutics today must maintain breadth and depth in physical chemistry, physical organic chemistry, bioengineering, nanotechnology and the life sciences in order to solve research problems that require integration basic science concepts from multiple disciplines with medical applications.
Contact
Robert Brown;     Phone: [17025085200];     Email: asiapharma@pharmaceuticalconferences.com
Topics
Regulatory Affairs, Intellectual Property Rights, Pharmacognosy and Phytochemistry, Advancements in Pharmaceutics, Trends in Nanotechnology, Industrial Pharmacy, Pharmacological Studies, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry and Molecular Biology, Clinical Pharmacy, Hospital Pharmacy, Pharmaceutical Care & Health Systems, Pharma Compliance.
93.
 
International Vaccines Congress
ID
857235
Dates
27 Jul 2017 - 28 Jul 2017
Location
Chicago, United States
Abstract
PULSUS is the publisher of peer reviewed scientific, technical, and medical journals and magazines. Since establishment 1984, has been instrumental in healthcare and medical dissemination. PULSUS expanded with the support from scientific societies and open its arm to conduct global medical and healthcare meetings. With immense please and support, PULSUS is honored to announced it International Vaccines Congress, which will be going to held in Chicago, USA during July 27-28, 2017.
Contact
Annah Brwon;     Email: vaccinescongress@protonmail.com
Topics
vaccines Congress, Vaccines Conference 2017, Vaccines Conference USA
Related subject(s)
94.
 
Pharmaceutics Meeting 2017 — “Global Experts Meeting on Pharmaceutics & Drug Delivery Systems”
ID
877182
Dates
31 Jul 2017 - 02 Aug 2017
Location
Melbourne, Australia
Contact
swapna sarah;     Phone: [8001012627];     Email: pharmaceutics@pharmameetings.com
Topics
Pre-Formulation, Formulation Aspects, Pharmacokinetics and Pharmacodynamics, Drug Targeting, Drug Delivery Routes, Nano Drug Delivery Systems, Nanotechnology in Drug Delivery, Pharmaceutical Nanotechnology, Smart Drug Delivery Systems, Applications of Biomaterials, Theranostics and Peptides and Protein Drug Delivery.
95.
 
Pharmacology Studies 2017 — International Conference on Pharmacology & Toxicology Studies
ID
859617
Dates
07 Aug 2017 - 09 Aug 2017
Location
Philadelphia, United States
Abstract
Scientific Synergy Conferences are delighted to welcome you all to the
Contact
Scientific Synergy;     Phone: [+1-888-623-5051];     Email: pharmacology@scientificsynergy.com
Topics
Pharmacology Studies 2017, Pharmacology Conference, Toxicology Conference, Scientific Synergy USA, Pharmacology Conference Philadelphia, Pharmacology Congress USA, Clinical Pharmacology event, Drug Toxicology, Pharmacology Case Reports, Forensic Toxicology.
96.
 
Biosimilars Asia 2017 — 8th Asian Biosimilars Congress
ID
841145
Dates
14 Aug 2017 - 16 Aug 2017
Location
Osaka, Japan
Abstract
Biosimilars Asia 2017 is a specially designed cluster conference. The main theme of the conference is
Contact
Victorya Jones;     Phone: [7025085200];     Email: biosimilarsasia@pharmaceuticalconferences.com
Topics
biosimilars, biologics, biosimilars conference, biologics conferences, biosimilars events, Biologics events, biosimilars workshops
97.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858889
Dates
11 Sep 2017 - 13 Sep 2017
Location
Clarion Hotel Prague, Czech Republic
98.
 
Formulation & Drug Delivery USA Congress
ID
871437
Dates
14 Sep 2017 - 15 Sep 2017
Location
Boston, United States
Abstract
Oxford Global are proud to present our Formulation & Drug Delivery USA Congress, taking place on 14 – 15 September 2017 in Boston. Over 150 delegates representing leading pharmaceutical organisations, biotech companies and internationally renowned research & academic institutions will be present to discuss and network. Over 40 case studies and presentations focused on exploring regulatory guidelines of both large and small molecule formulations, future applications of protein and peptide formulations, recent advancements in nanoparticles as drug delivery systems, combination drug delivery devices and improving the bioavailability of compounds.
Contact
Guillaume Alonso;     Phone: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
drug formulation, drug delivery, small molecules, large molecules
99.
 
Training — Validation & Transfer of Methods for Pharmaceutical Analysis
ID
864105
Dates
27 Sep 2017 - 29 Sep 2017
Location
Berlin, Germany
100.
 
Principles of Pharma Market Access in Europe
ID
834260
Dates
03 Oct 2017 - 04 Oct 2017
Location
Brussels, Belgium
Abstract
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
101.
 
Value Pricing for Market Access - The Fundamentals
ID
834332
Dates
05 Oct 2017 - 06 Oct 2017
Location
Brussels, Belgium
Abstract
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
102.
 
Safety & Selectivity in the Scale-Up of Chemical Reactions
ID
858854
Dates
09 Oct 2017 - 10 Oct 2017
Location
Lisbon , Portugal
103.
 
Scaling from Milligrams to 1-2kg: Making the First GMP Batch
ID
858853
Dates
09 Oct 2017 - 10 Oct 2017
Location
Lisbon , Portugal
104.
 
Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries
ID
858885
Dates
11 Oct 2017 - 13 Oct 2017
Location
Lisbon , Portugal
105.
 
Health Economics for Non-Health-Economists
ID
834383
Dates
12 Oct 2017 - 13 Oct 2017
Location
Zurich, Switzerland
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
106.
 
PHARMATechExpo — VIII International Exhibition of Equipment and Technologies for the Pharmaceutical Industry
ID
877240
Dates
17 Oct 2017 - 19 Oct 2017
Location
Kiev, Ukraine
Abstract
The only one Exhibition in Ukraine where is presented the entire pharmaceutical production process: from development of substances and quality control of raw materials, equipment for pharmaceutical production and packaging technologies to transportation, storage of pharmaceuticals and staff recruitment. During the exhibition, in the framework of the scientific-practical program Days of pharmaceutical industry will be held conferences, seminars, round tables and presentations.
Contact
Olga Babii;     Phone: [+380442061015];     Email: expo@pharmatechexpo.com.ua
Topics
raw materials and components, production and nonproduction equipment, packing and packing equipment, сlean rooms technologies, technologies and equipment for water supply, water treatment and sewage treatment, industrial refrigeration and climatic equipment for pharmaceutical enterprises, staff training and educational institutions, services for pharmaceutical companies
107.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864060
Dates
18 Oct 2017 - 20 Oct 2017
Location
London, United Kingdom
108.
 
MedTechConf Sarajevo
ID
868322
Dates
19 Oct 2017 - 20 Oct 2017
Location
Sarajevo, Bosnia and Herzegovina
Contact
Edina Musmulja;     Phone: [+ 387 61 914 178];     Email: info@medtechconf.com
Topics
Regenerative Medicine & Biological Materials, Future Drugs, Three-dimensional Echocardiography, Neuroscience, Health Economics, Artificial Intelligence & New Technology Development, Future Healthcare Ecosystems & Medical Billing
109.
 
ICCP — 5th International Conference on Clinical Pharmacy
ID
858237
Dates
23 Oct 2017 - 24 Oct 2017
Location
Florida, United States
Abstract
Clinical Pharmacy Conference aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results about all aspects of Clinical Pharmacy. It also provides the disciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Clinical Pharmacy. All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers, and e-posters. Also, high-quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Clinical Pharmacy are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers, and e-posters that address themes and topics of the conference, including figures, tables, and references of novel research material. The conference abstracts and proceedings book and certificate of presentation will be distributed to the conference participants at the conference registration desk. In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of biomedical, pharmaceutical, and clinical sciences by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Clinical Pharmacy.
Contact
Victor Badoni;     Phone: [7025085200 Ext: 8047];     Email: badonivictor@outlook.com
Topics
Pharma Conferences, Pharmacy Conferences, Clinical Pharmacy Conferneces, Pharmaceutical Conferences
110.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858862
Dates
31 Oct 2017 - 02 Nov 2017
Location
Boston , United States
111.
 
International Pharmaceutical Conference and Expo
ID
875921
Dates
14 Nov 2017 - 16 Nov 2017
Location
Philadelphia,, United States
Abstract
iPharma 2017 cordially welcomes you to the City of Philadelphia, USA during November 14-16, 2017. Conference will witness academicians and business professionals discussing the soundest issues related to pharmaceuticals and will offer unparalleled business opportunities and access to new markets in Health Science.
Contact
serena martin;     Phone: [6193784793];     Email: serena@ipharmaconference.com
Topics
Pharmaceutical, Drug Discovery, Drug Delivery Systems, Pharmaceutical Nanotechnology, Drug Therapy, Pharmaceutical Formulations, Clinical Trials, Neuropharmacology, Biopharmaceutical, Nutraceuticals, Pharma Medicines
112.
 
Biomarkers Congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
879212
Dates
27 Nov 2017 - 28 Nov 2017
Location
Atlanta, Georgia
Abstract
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact
Safina Robinson;     Phone: [2037691765];     Email: biomarkers@cmesocietyconferences.org
Topics
Biomarkers Conference, Biomarkers Conference 2017, Biomarkers Conferences, Cancer Biomarkers Conference, Biomarker Conferences, Cancer Biomarker Conferences, Biomarkers Congress 2017, Biomarkers Society Conferences, Biomarker Conferences 2017
113.
 
Biomarkers congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
867773
Dates
27 Nov 2017 - 28 Nov 2017
Location
Atlanta, United States
Abstract
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact
Rachel Mathews;     Email: america@cmesociety.com
Topics
Biomarkers Conference, Biomarkers Conference 2017, Biomarkers Conference December, Cancer Biomarkers, Cancer Conferences, Cancer Conferences 2017, Biomarkers Events, Biomarkers Society Conferences, Biomarkers Congress
Related subject(s)
114.
 
Training — Validation & Transfer of Methods for Biopharmaceutical Analysis
ID
864103
Dates
27 Nov 2017 - 29 Nov 2017
Location
Berlin, Ireland
115.
 
 International summit on — Medical, Pharma & drug studies
ID
875624
Dates
29 Nov 2017 - 30 Nov 2017
Location
Brisbane, Australia
Abstract
The Innovate Medicine 2017 team is the premier medical conference event producer. At these medical conference events, physicians, Hospital & Clinical professionals, Medical Students are able to latest updates in Medical Pharma & Drug Research Studies insights, explore new challenges in health care, surgeries, hospital management, medical treatment and care as well as review clinical case studies in order to understand how best to deal with specific situations
Contact
aarondurant;     Phone: [61-1-800-025-686];     Email: pharma@innovatecolloquium.com
116.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834356
Start date
30 Nov 2017
Location
Brussels, Belgium
Abstract
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
117.
 
Digital Pathology Congress
ID
877146
Dates
30 Nov 2017 - 01 Dec 2017
Location
London, United Kingdom
Abstract
The conference is part of the successful Personalised Medicine series which includes events on precision medicine, synthetic biology, the human microbiome, biologics and digital PCR. The meeting is also the sister meeting to the US and Asian Digital Pathology meetings taking place in July and August respectively.
Contact
Jane Wiliams;     Email: jane@globalengage.co.uk
118.
 
Principles of Pharma Market Access in Europe
ID
834270
Dates
05 Dec 2017 - 06 Dec 2017
Location
London, United Kingdom
Abstract
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
119.
 
Value Pricing for Market Access - The Fundamentals
ID
834353
Dates
07 Dec 2017 - 08 Dec 2017
Location
London, United Kingdom
Abstract
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
120.
 
Health Economics for Non-Health-Economists
ID
834393
Dates
14 Dec 2017 - 15 Dec 2017
Location
Brussels, Belgium
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
121.
 
Eilat XIV — Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices
ID
839627
Dates
13 May 2018 - 16 May 2018
Location
Madrid, Spain
Abstract
Based on the success of the past thirteen Eilat Conferences on New Antiepileptic Drugs and Devices (AEDs), the Organizing Committee takes pleasure in inviting you to participate in the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV), which will take place in Madrid, Spain, May 13 - 16, 2018.

For the forthcoming conference, we will be continuing with debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments.

Contact
Vikki Hyman;     Phone: [+97235175150];     Email: eilat@target-conferences.com
Topics
epilepsy, antiepileptic, drugs, devices, treatments, conference, congress
Related subject(s)
Event website
RNA Therapeutics conference
Superbugs & Superdrugs Conference
Pharmaceutical Freeze Drying Technology, 8th & 9th May 2017, Copthorne Tara Hotel, London UK
Pain Therapeutics, 22nd & 23rd May 2017, Copthorne Tara Hotel, London UK
Pre-Filled Syringes West Coast, 5th & 6th June 2017, Hyatt Regency Mission Bay, San Diego, California, USA

Good to know...

You can advertise your event or services in this space.

Last updated: 21 February 2017